|
|
Office Locations:
|
401 Florence St. Suite 200
Palo Alto, CA 94301
Phone: 650-330-0322
Fax: 650-330-0577
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Founded in 1999, Kenson Ventures provides seed money/funds and strategic advice to start-ups, partnerships, and established companies focusing in the biotechnology and life science areas. Kenson Ventures also considers and participates in co-investment with other institutions. These companies range from the development of novel drugs, discovery of genomics-based drug targets and leads to the development of research tools in molecular and cellular biology. The firm's range of investment varies from $500,000 to $3 million U.S. dollars. Since Kenson Ventures' inception, the firm has been involved in and financed over 20 companies representing a broad spectrum of technology platforms.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
